Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ATAI save search
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
Published: 2024-03-28 (Crawled : 11:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 0.84%
H: 13.02%
C: 9.14%
HTGC F | $17.965 0.03% 150K
|
Finance
|
| O: -0.05%
H: 0.79%
C: 0.49%
life year sciences financial results
atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression
Published: 2024-03-27 (Crawled : 11:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 4.05%
H: 1.11%
C: -0.56%
bpl-003 label life positive depression treatment sciences results study
atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
Published: 2024-03-04 (Crawled : 13:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 2.82%
H: 0.0%
C: -4.57%
vls-01 first life sciences trial
atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference
Published: 2024-02-28 (Crawled : 22:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 2.04%
H: 2.0%
C: -3.0%
conference health life care sciences
atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
Published: 2024-02-06 (Crawled : 22:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 0.0%
H: 0.56%
C: -5.03%
CMRX | $0.916 0.15% 22K
|
Health Technology
|
| O: 1.18%
H: 0.46%
C: -2.35%
life sciences financial
atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics
Published: 2024-01-04 (Crawled : 12:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 6.67%
H: 10.94%
C: 7.5%
HTGC F | $17.965 0.03% 150K
|
Finance
|
| O: 0.0%
H: 3.36%
C: 2.64%
life sciences
atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)
Published: 2024-01-02 (Crawled : 13:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 0.71%
H: 19.01%
C: 19.01%
HTGC F | $17.965 0.03% 150K
|
Finance
|
| O: -0.12%
H: 0.54%
C: 0.48%
emp-01 life positive sciences topline results study
atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 4.35%
H: 5.0%
C: 4.58%
HTGC F | $17.965 0.03% 150K
|
Finance
|
| O: -2.68%
H: 1.92%
C: 1.02%
CMPS | $8.31 -0.12% 42K
|
Health Technology
|
| O: 3.42%
H: 9.54%
C: 5.32%
life pipeline sciences financial results
atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit
Published: 2023-10-06 (Crawled : 20:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
| Email alert
Add to watchlist
biotech life sciences
atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants
Published: 2023-10-02 (Crawled : 20:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 6.45%
H: 5.3%
C: 5.3%
HTGC F | $17.965 0.03% 150K
|
Finance
|
| O: -0.56%
H: 0.69%
C: -1.5%
vls-01 life sciences study
atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
Published: 2023-09-14 (Crawled : 12:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 1.42%
H: 1.4%
C: 1.4%
conference life sciences global
atai Life Sciences to Participate in Upcoming September Investor Conferences
Published: 2023-09-06 (Crawled : 20:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 0.0%
H: 2.08%
C: 0.69%
life sciences
Atossa Appoints Life Sciences Financial and Operations Industry Veteran Greg Weaver as Chief Financial Officer
Published: 2023-06-01 (Crawled : 13:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -3.91%
ELOX | $0.98 93K
|
Health Technology
|
| O: -1.78%
H: 6.96%
C: 5.9%
ATOS | $1.62 -5.26% 240K
|
Health Technology
|
| O: -3.23%
H: 5.99%
C: 2.5%
life sciences financial
atai Life Sciences to Participate in Upcoming June Investor Conferences
Published: 2023-06-01 (Crawled : 11:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -3.91%
life sciences
atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates
Published: 2023-05-11 (Crawled : 11:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 0.0%
H: 1.0%
C: -2.0%
HTGC F | $17.965 0.03% 150K
|
Finance
|
| O: -0.15%
H: 0.66%
C: 0.07%
life pipeline sciences financial results
atai Life Sciences to Participate in Upcoming May Investor Conference
Published: 2023-05-02 (Crawled : 21:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 1.59%
H: 1.82%
C: -1.04%
conference life sciences
atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at the 2023 SOBP Annual Meeting
Published: 2023-04-28 (Crawled : 13:00) - biospace.com/
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 0.0%
H: 6.15%
C: 2.14%
HTGC F | $17.965 0.03% 150K
|
Finance
|
| O: -0.08%
H: 1.25%
C: 0.53%
grx-917 life presentation sciences meeting
atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)
Published: 2023-04-13 (Crawled : 11:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 0.0%
H: 12.64%
C: 9.89%
HTGC F | $17.965 0.03% 150K
|
Finance
|
| O: 0.24%
H: 2.64%
C: 1.92%
pcn-101 life sciences study
atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights
Published: 2023-03-24 (Crawled : 12:00) - biospace.com/
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 0.84%
H: 5.0%
C: 4.17%
HTGC F | $17.965 0.03% 150K
|
Finance
|
| O: -1.15%
H: 3.9%
C: 3.49%
life year pipeline sciences financial results
atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates
Published: 2023-03-06 (Crawled : 12:00) - globenewswire.com
ATAI | $2.075 0.24% 270K
|
Manufacturing
|
| O: 0.64%
H: 6.37%
C: -0.64%
HTGC F | $17.965 0.03% 150K
|
Finance
|
| O: 0.0%
H: 2.26%
C: 1.38%
sciences life pipeline
Gainers vs Losers
| 47% | 53% |
Top 10 Gainers
TPET | $0.4801 107.75% 16M
|
n/a
WISA 4 | $3.17 81.14% 36M
|
Electronic Technology
PALI | $7.41 78.13% 14M
|
Manufacturing
SPCB | $0.4278 55.0% 17M
|
Electronic Technology
BTTR | $7.61 49.22% 1.8M
|
Manufacturing
PRSO | $1.79 40.95% 25M
|
Manufacturing
DYNT | $0.5203 40.47% 17M
|
Health Technology
JAGX | $0.1668 40.4% 110M
|
Health Technology
MCBC | $13.84 39.38% 450K
|
Finance
SNGX | $0.5155 33.52% 3.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.